Insider Trading & Ownership of Abingworth LLP

Location
London
Summary
The estimated value of insider holdings of Abingworth LLP is at least $783,121,184 dollars as of 23 Mar 2022. Abingworth LLP is the 10%+ Owner of SOLENO THERAPEUTICS INC and owns shares of SOLENO THERAPEUTICS INC (SLNO) stock worth about $657.56M. Abingworth LLP is the 10%+ Owner of Sierra Oncology, Inc. and owns shares of Sierra Oncology, Inc. stock worth about $72.28M. Abingworth LLP is the 10%+ Owner of Vera Therapeutics, Inc. and owns shares of Vera Therapeutics, Inc. (VERA) stock worth about $53.28M.
Signature
/s/ John Heard
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Abingworth LLP and return when a new Insider Trading filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.

Create free account and return here Already have an account? Sign in and return here

Key facts

  • Abingworth LLP has 5 issuer positions tracked on this page.
  • Estimated disclosed ownership value: $783,121,184.
  • Recent insider filing activity is available below.

Change

  • Largest disclosed position: SOLENO THERAPEUTICS INC ($657,560,041).
  • Past-year value change for that position: .

Research use

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Evidence

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Abingworth LLP

Insider Transactions Reported by Abingworth LLP:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .